- Home
- CVAC vs NIE Comparison
CVAC vs NIE Comparison
Compare CVAC & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- NIE
- Stock Information
- Founded
- CVAC 2000
- NIE 2007
- Country
- CVAC Germany
- NIE United States
- Employees
- CVAC N/A
- NIE N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- NIE Investment Managers
- Sector
- CVAC Health Care
- NIE Finance
- Exchange
- CVAC Nasdaq
- NIE Nasdaq
- Market Cap
- CVAC 764.4M
- NIE 697.4M
- IPO Year
- CVAC 2020
- NIE N/A
- Fundamental
- Price
- CVAC $5.44
- NIE $22.80
- Analyst Decision
- CVAC Buy
- NIE
- Analyst Count
- CVAC 3
- NIE 0
- Target Price
- CVAC $9.00
- NIE N/A
- AVG Volume (30 Days)
- CVAC 2.1M
- NIE 70.5K
- Earning Date
- CVAC 08-14-2025
- NIE 01-01-0001
- Dividend Yield
- CVAC N/A
- NIE 9.04%
- EPS Growth
- CVAC N/A
- NIE N/A
- EPS
- CVAC 0.87
- NIE N/A
- Revenue
- CVAC $566,039,775.00
- NIE N/A
- Revenue This Year
- CVAC N/A
- NIE N/A
- Revenue Next Year
- CVAC $24.04
- NIE N/A
- P/E Ratio
- CVAC $6.34
- NIE N/A
- Revenue Growth
- CVAC 787.60
- NIE N/A
- 52 Week Low
- CVAC $2.37
- NIE $18.61
- 52 Week High
- CVAC $5.72
- NIE $22.47
- Technical
- Relative Strength Index (RSI)
- CVAC 68.03
- NIE 44.96
- Support Level
- CVAC $4.07
- NIE $22.74
- Resistance Level
- CVAC $5.58
- NIE $23.20
- Average True Range (ATR)
- CVAC 0.20
- NIE 0.29
- MACD
- CVAC 0.07
- NIE -0.11
- Stochastic Oscillator
- CVAC 83.08
- NIE 5.69
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments such as aerospace and defense, banks, IT services, software, and others.